Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bochner

Showing results (101-110 of 166) with videos related to

Pageof 17
Sort By:
British Journal of Pharmacology|August 1, 1992
Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenalineD M Vanags, S E Rodgers, E M Duncan, et al.
Biopharmaceutics & Drug Disposition|August 1, 1990
The relationship between the pharmacokinetics of ibuprofen enantiomers and the dose of racemic ibuprofen in humansA M Evans, R L Nation, L N Sansom, et al.
Archives of Neurology|July 1, 1974
Diphenylhydantoin concentrations in salivaF Bochner, W D Hooper, J M Sutherland, et al.
British Journal of Clinical Pharmacology|November 9, 2000
Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patientsD J Foster, A A Somogyi, K R Dyer, et al.
Pain|February 13, 2001
Hyperalgesic responses in methadone maintenance patientsM Doverty, J M White, A A Somogyi, et al.
Australian and New Zealand Journal of Medicine|August 1, 1973
The effect of certain drugs on the plasma protein binding of phenytoinW D Hooper, J M Sutherland, F Bochner, et al.
British Journal of Clinical Pharmacology|January 1, 1984
Plasma cortisol delivery from oral cortisol and cortisone acetate: relative bioavailabilityV J Heazelwood, J P Galligan, G R Cannell, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Aspirin pharmacokinetics in migraine. The effect of metoclopramideL M Ross-Lee, M J Eadie, V Heazlewood, et al.
Clinical Pharmacology and Therapeutics|September 1, 1996
The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humansD A Capon, F Bochner, N Kerry, et al.
Clinical Pharmacology and Therapeutics|September 1, 1973
The renal handling of diphenylhydantoin and 5-(p-hydroxyphenyl)-5-phenylhydantoinF Bochner, W D Hooper, J M Sutherland, et al.
Pageof 17

Showing results (101-110 of 166) with videos related to

Sort By:
Pageof 17
British Journal of Pharmacology|August 1, 1992
Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenalineD M Vanags, S E Rodgers, E M Duncan, et al.
Biopharmaceutics & Drug Disposition|August 1, 1990
The relationship between the pharmacokinetics of ibuprofen enantiomers and the dose of racemic ibuprofen in humansA M Evans, R L Nation, L N Sansom, et al.
Archives of Neurology|July 1, 1974
Diphenylhydantoin concentrations in salivaF Bochner, W D Hooper, J M Sutherland, et al.
British Journal of Clinical Pharmacology|November 9, 2000
Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patientsD J Foster, A A Somogyi, K R Dyer, et al.
Pain|February 13, 2001
Hyperalgesic responses in methadone maintenance patientsM Doverty, J M White, A A Somogyi, et al.
Australian and New Zealand Journal of Medicine|August 1, 1973
The effect of certain drugs on the plasma protein binding of phenytoinW D Hooper, J M Sutherland, F Bochner, et al.
British Journal of Clinical Pharmacology|January 1, 1984
Plasma cortisol delivery from oral cortisol and cortisone acetate: relative bioavailabilityV J Heazelwood, J P Galligan, G R Cannell, et al.
European Journal of Clinical Pharmacology|January 1, 1983
Aspirin pharmacokinetics in migraine. The effect of metoclopramideL M Ross-Lee, M J Eadie, V Heazlewood, et al.
Clinical Pharmacology and Therapeutics|September 1, 1996
The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humansD A Capon, F Bochner, N Kerry, et al.
Clinical Pharmacology and Therapeutics|September 1, 1973
The renal handling of diphenylhydantoin and 5-(p-hydroxyphenyl)-5-phenylhydantoinF Bochner, W D Hooper, J M Sutherland, et al.
Pageof 17